Zymeworks appoints Carlos Campoy to board; director Natalie Sacks resigns effective June 30, 2023

Zymeworks Inc.

Carlos Campoy appointed as Class I director effective June 30, 2023, term expiring at 2025 AGM.
Campoy receives initial grant of 50,000 common shares as part of standard non-employee director compensation.
Natalie Sacks resigned effective June 30, 2023; resignation not due to any disagreement with the company.
Campoy joins audit and nominating/corporate governance committees; Kelvin Neu named chair of R&D committee.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Carlos Campoy

Director

ZYME · Zymeworks Inc.

Effective: 2023-06-30
Filed: June 29, 2023, 7:59 PM ET

appointed Mr. Carlos Campoy as a director of the Company, effective as of June 30, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carlos Campoy was appointed as Director at Zymeworks Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Mr. Carlos Campoy as a director of the Company, effective as of June 30, 2023.

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-178592

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.